http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100961287-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2002-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100961287-B1
titleOfInvention Hetero-bicyclic CrF antagonist
abstract The present invention is mediated by a compound of formula (I) and stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof, methods of preparation thereof, pharmaceutical compositions containing the same, and corticosteroid stimulating hormone release factor (CRF) Its use is provided in the treatment of symptoms.n n n <Formula I>n n n n n n n n Wheren n n R is aryl or heteroaryl, each of which is halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl , May be substituted by 1 to 4 groups selected from halo C 1 -C 6 alkoxy, —C (O) R 5 , nitro, —NR 6 R 7 , cyano and R 8 groups;n n n R 1 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, halo C 1 -C 6 alkyl, halo C 1 -C 6 alkoxy, halogen, NR 6 R 7 Or cyano;n n n R 2 is hydrogen, a C 3 -C 7 cycloalkyl or R 8 group;n n n R 3 is a C 3 -C 7 cycloalkyl or R 9 group; orn n n R 2 and R 3 together with N form a 5 to 14 membered heterocycle which may be substituted by 1 to 3 R 10 groups;n n n R 4 is hydrogen, C 1 -C 6 alkyl, halogen or halo C 1 -C 6 alkyl;n n n R 5 is C 1 -C 4 alkyl, —OR 6 or —NR 6 R 7 ;n n n R 6 is hydrogen or C 1 -C 6 alkyl;n n n R 7 is hydrogen or C 1 -C 6 alkyl;n n n R 8 is a 5-6 membered heterocycle, which heterocycle may be saturated or may have 1 to 3 double bonds, and may be substituted by one or more R 11 groups;n n n R 9 is C 3 -C 7 cycloalkyl, C 1 -C 6 alkoxy, halo C 1 -C 6 alkoxy, hydroxy, halo, C 1, which may be substituted by one or more groups selected from -C 6 alkyl C 1 -C 6 alkyl;n n n R 10 is an R 8 group, C 3 -C 7 cycloalkyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 Alkynyl, halo C 1 -C 6 alkoxy, hydroxy, halogen, nitro, cyano, C (O) NR 6 R 7 , phenyl which may be substituted by 1 to 4 R 11 groups;n n n R 11 is C 3 -C 7 cycloalkyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, halo C 1 -C 6 alkoxy, hydroxy, halogen, nitro, cyano or C (O) NR 6 R 7 ;n n n X is carbon or nitrogen;n n n n is 1 or 2.
priorityDate 2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468195985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466621969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467502239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466621974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466547965

Total number of triples: 58.